Influence of nanostructured lipid carriers (NLC) on the physical properties of the Cutanova Nanorepair Q10 cream and the in vivo skin hydration effect

International Journal of Pharmaceutics

Volumn 396, Issue 1-2, 2010, Pages 166-173

  Pardeike, Jana ^a,b   Schwabe, Kay ^a,c   Müller, Rainer H ^a  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

^b UNIVERSITY OF GRAZ   (Austria)

^c Dr Rimpler GmbH   (Germany)

Author keywords

Coenzyme Q10; Cosmetic product; Dermal application; Epicutaneous patch test; Nanostructured lipid carriers (NLC); Skin hydration

Indexed keywords

COSMETIC; NANOCARRIER; NANOSTRUCTURED LIPID CARRIER; PLACEBO; UBIDECARENONE; UNCLASSIFIED DRUG; WATER OIL CREAM; DRUG CARRIER; LIPID; NANOMATERIAL; OINTMENT; UBIQUINONE; WATER;

ADULT; ARTICLE; CONTROLLED STUDY; CREAM; DIFFERENTIAL SCANNING CALORIMETRY; FEMALE; FLOW KINETICS; HUMAN; HUMAN EXPERIMENT; HYDRATION; IN VIVO STUDY; LASER DIFFRACTION; MOLECULAR STABILITY; NORMAL HUMAN; PATCH TEST; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; QUESTIONNAIRE; SHEAR STRESS; SKIN; SKIN HYDRATION; SKIN IRRITATION; ANALOGS AND DERIVATIVES; CHEMISTRY; CONSUMER ATTITUDE; CONTROLLED CLINICAL TRIAL; DRUG EFFECTS; DRUG FORMULATION; DRUG STABILITY; INTRADERMAL DRUG ADMINISTRATION; MEDICINAL CHEMISTRY; METABOLISM; MIDDLE AGED; NANOTECHNOLOGY; OINTMENT; PARTICLE SIZE; PHARMACEUTICS; PROCEDURES; SINGLE BLIND PROCEDURE; TIME; TRANSITION TEMPERATURE; YOUNG ADULT;

ADMINISTRATION, CUTANEOUS; ADULT; CALORIMETRY, DIFFERENTIAL SCANNING; CHEMISTRY, PHARMACEUTICAL; CONSUMER SATISFACTION; COSMETICS; DRUG CARRIERS; DRUG COMPOUNDING; DRUG STABILITY; FEMALE; HUMANS; LIPIDS; MIDDLE AGED; NANOSTRUCTURES; NANOTECHNOLOGY; OINTMENTS; PARTICLE SIZE; PATCH TESTS; RHEOLOGY; SINGLE-BLIND METHOD; SKIN; TECHNOLOGY, PHARMACEUTICAL; TIME FACTORS; TRANSITION TEMPERATURE; UBIQUINONE; WATER; YOUNG ADULT; CONSUMER BEHAVIOR;

EID: 77955050421     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2010.06.007     Document Type: Article

References (67)

1. 1977 Kosmetik-Verordnung in der Fassung der Bekanntmachung vom 7. Oktober 1997 (BGBl. I S. 2410), zuletzt geändert durch Artikel 1 der Verordnung vom 4. Juli 2008 (BGBl. I S. 1226).
2. 2005 Lebensmittel-und Futtermittelgesetzbuch in der Fassung der Bekanntmachung vom 26. April 2006 (BGBl. I S. 945), zuletzt geändert durch Artikel 12 des Gesetzes vom 26. Februar 2008 (BGBl. I S. 215).
3. Beckman K.B., Ames B.N. The free radical theory of aging matures. Physiol. Rev. 1998, 78:547-581.
4. Bentinger M., Brismar K., Dallner G. The antioxidant role of coenzyme Q. Mitochondrion 2007, S41-S50.
5. Beyer R.E. Inhibition by coenzyme Q of ethanol- and carbon tetrachloride-stimulated lipid peroxidation in vivo and catalyzed by microsomal and mitochondrial systems. Free Radic. Biol. Med. 1988, 5:297-303.
6. Beyer R.E., Burnett B.A., Cartwright K.J., Edington D.W., Falzon M.J., Kreitman K.R., Kuhn T.W., Ramp B.J., Rhee S.Y., Rosenwasser M.J. Tissue coenzyme Q (ubiquinone) and protein concentrations over the life span of the laboratory rat. Mech. Ageing Dev. 1985, 32:267-281.
7. Chakravarti B., Chakravarti D.N. Oxidative modification of proteins: age-related changes. Gerontology 2006, 53:128-139.
8. Chen H., Chang X., Du D., Liu W., Liu J., Weng T., Yang Y., Xu H., Yang X. Podophyllotoxin-loaded solid lipid nanoparticles for epidermal targeting. J. Control. Rel. 2006, 110:296-306.
9. Dingler A. Feste Lipid-Nanopartikel als kolloidale Wirkstoffträgersysteme zur dermalen Applikation 1998, Freie Universität Berlin, Berlin.
10. Dingler A., Hildebrand G., Niehus H., Müller R.H. Cosmetic anti-aging formulation based on vitamin E-loaded solid lipid nanoparticles 1998, Controlled Release Society.
11. Ernster L., Dallner G. Biochemical, physiological and medical aspects of ubiquinone function. Biochim. Biophys. Acta 1995, 1271:195-204.
12. Fang J.Y., Fang C.L., Liu C.H., Su Y.H. Lipid nanoparticles as vehicles for topical psoralen delivery: solid lipid nanoparticles (SLN) versus nanostructured lipid carriers (NLC). Eur. J. Pharm. Biopharm. 2008, 70:633-640.
13. Forsmark-Andree P., Ernster L. Evidence for a protective effect of endogenous ubiquinol against oxidative damage to mitochondrial protein and DNA during lipid peroxidation. Mol. Asp. Med. 1994, s73-s81.
14. Han F., Li S., Yin R., Shi X., Jia Q. Investigation of nanostructured lipid carriers for transdermal delivery of flurbiprofen. Drug Dev. Ind. Pharm. 2008, 34:453-458.
15. Harman D. Aging: a theory based on free radical and radiation chemistry. J. Gerontol. 1996, 11:298-300.
16. Harvell J.D., Lammintausta K., Maibach H.I. Irritant contact dermatitis. Practical Contact Dermatitis 1995, McGraw-Hill, New York. J.D. Guin (Ed.).
17. Jee J.P., Lim S.J., Park J.S., Kim C.K. Stabilization of all-trans retinol by loading lipophilic antioxidants in solid lipid nanoparticles. Eur. J. Pharm. Biopharm. 2006, 63:134-139.
18. Jenning V., Gohla S.H. Encapsulation of retinoids in solid lipid nanoparticles (SLN). J. Microencapsul. 2001, 18:149-158.
19. Jenning V., Gysler A., Schäfer-Korting M., Gohla S.H. Vitamin A loaded solid lipid nanoparticles for topical use: occlusive properties and drug targeting to the upper skin. Eur. J. Pharm. Biopharm. 1999, 49:211-218.
20. Jenning V., Schäfer-Korting M., Gohla S. Vitamin A-loaded solid lipid nanoparticles for topical use: drug release properties. J. Control. Rel. 2000, 66:115-126.
21. Joshi M., Patravale V. Formulation and evaluation of nanostructured lipid carrier (NLC)-based gel of valdecoxib. Drug Dev. Ind. Pharm. 2006, 32:911-918.
22. Joshi M., Patravale V. Nanostructured lipid carrier (NLC) based gel of celecoxib. Int. J. Pharm. 2008, 346:124-132.
23. Kimber I., Basketter D.A., Berthold K., Butler M., Garrigue J.L., Lea L., Newsome C., Roggeband R., Steiling W., Stropp G., Waterman S., Wiemann C. Skin sensitization testing in potency and risk assessment. Toxicol. Sci. 2001, 59:198-208.
24. Kohen R., Gati I. Skin low molecular weight antioxidants and their role in aging and in oxidative stress. Toxicology 2000, 148:149-157.
25. Liu J., Hu W., Chen H., Ni Q., Xu H., Yang X. Isotretinoin-loaded solid lipid nanoparticles with skin targeting for topical delivery. Int. J. Pharm. 2007, 328:191-195.
26. Lucks, J.S., Müller, R.H. 1991. Medication vehicles made of solid lipid particles (solid lipid nanospheres SLN) EP0000605497.
27. Medvedev Z.A. An attempt at a rational classification of theories of ageing. Biol. Rev. Camb. Philos. Soc. 1990, 65:375-398.
28. Mei Z., Chen H., Weng T., Yang Y., Yang X. Solid lipid nanoparticle and microemulsion for topical delivery of triptolide. Eur. J. Pharm. Biopharm. 2003, 56:189-196.
29. Moore A. The biochemistry of beauty. The science and pseudo-science of beautiful skin. EMBO Rep. 2002, 3:714-717.
30. Müller R.H., Dingler A. The next generation after liposomes: solid lipid nanoparticles (SLN Lipopearls) as dermal carrier in cosmetics. Eurocosmetics 1998, 7/8:19-26.
31. Müller R.H., Immig H., Hommoss A. Prolonged release of parfumes by nano lipid carriers (NLC) technology. Eurocosmetics 2007, 11:12.
32. Müller R.H., Petersen R.D., Hommoss A., Pardeike J. Nanostructured lipid carriers (NLC) in cosmetic dermal products. Adv. Drug Deliv. Rev. 2007, 59:522-530.
33. Müller R.H., Mäder K., Gohla S. Solid lipid nanoparticles (SLN) for controlled drug delivery-a review of the state of art. Eur. J. Pharm. Biopharm. 2000, 50:161-177.
34. Müller R.H., Ruhl D., Runge S., Schulze-Forster K., Mehnert W. Cytotoxicity of solid lipid nanoparticles as a function of the lipid matrix and the surfactant. Pharm. Res. 1997, 14:458-462.
35. Pardeike J., Hommoss A., Müller R.H. Lipid nanoparticles (SLN NLC) in cosmetic and pharmaceutical dermal products. Int. J. Pharm. 2008, 366:170-184.
36. Pardeike J., Müller R.H. Coenzyme Q10 loaded NLCs: preparation, occlusive properties and penetration enhancement. Pharm. Technol. Eur. 2007, 19:46-49.
37. Pardeike J., Müller R.H. Physical stability of nanostructured lipid carriers (NLC) in an o/w urea cream. Annual Meeting of the Controlled Release Society (CRS) 2007, Controlled Release Society, Long Beach, USA.
38. Pathak P., Nagarsenker M. Formulation and evaluation of lidocaine lipid nanosystems for dermal delivery. AAPS PharmSciTech 2009, 10:985-992.
39. Pena L.E., Lee B.L., Stearns J.F. Secondary structural rheology of a model cream. J. Soc. Cosmet. Chem. 1994, 45:77-84.
40. Puglia C., Blasi P., Rizza L., Schoubben A., Bonina F., Rossi C., Ricci M. Lipid nanoparticles for prolonged topical delivery: an in vitro and in vivo investigation. Int. J. Pharm. 2008, 357:295-304.
41. Rabe J.H., Mamelak A.J., Mcelgunn P.J., Morison W.L., Sauder D.N. Photoaging: mechanisms and repair. J. Am. Acad. Dermatol. 2006, 55:1-19.
42. Ricci M., Puglia C., Bonina F., Di Giovanni C., Giovagnoli S., Rossi C. Evaluation of indomethacin percutaneous absorption from nanostructured lipid carriers (NLC): in vitro and in vivo studies. J. Pharm. Sci. 2005, 94:1149-1159.
43. Sanna V., Gavini E., Cossu M., Rassu G., Giunchedi P. Solid lipid nanoparticles (SLN) as carriers for the topical delivery of econazole nitrate: in-vitro characterization, ex-vivo and in-vivo studies. J. Pharm. Pharmacol. 2007, 59:1057-1064.
44. Santos M.C., Mehnert W., Schäfer-Korting M. Solid lipid nanoparticles as drug carriers for topical glucocorticoids. Int. J. Pharm. 2000, 196:165-167.
45. Santos M.C., Mehnert W., Schaller M., Korting H.C., Gysler A., Haberland A., Schäfer-Korting M. Drug targeting by solid lipid nanoparticles for dermal use. J. Drug Target. 2002, 10:489-495.
46. Scholer N., Olbrich C., Tabatt K., Muller R.H., Hahn H., Liesenfeld O. Surfactant, but not the size of solid lipid nanoparticles (SLN) influences viability and cytokine production of macrophages. Int. J. Pharm. 2001, 221:57-67.
47. Shah K.A., Date A.A., Joshi M.D., Patravale V.B. Solid lipid nanoparticles (SLN) of tretinoin: potential in topical delivery. Int. J. Pharm. 2007, 345:163-171.
48. Shindo Y., Witt E., Han D., Epstein W., Packer L. Enzymic and non-enzymic antioxidants in epidermis and dermis of human skin. J. Invest. Dermatol. 1994, 102:122-124.
49. Silva A.C., Santos D., Ferreira D.C., Souto E.B. Minoxidil-loaded nanostructured lipid carriers (NLC): characterization and rheological behaviour of topical formulations. Pharmazie 2009, 64:177-182.
50. Sivaramakrishnan R., Nakamura C., Mehnert W., Korting H.C., Kramer K.D., Schafer-Korting M. Glucocorticoid entrapment into lipid carriers-characterisation by parelectric spectroscopy and influence on dermal uptake. J. Control. Rel. 2004, 97:493-502.
51. Song C., Liu S. A new healthy sunscreen system for human: solid lipid nanoparticles as carrier for 3,4,5-trimethoxybenzoylchitin and the improvement by adding vitamin E. Int. J. Biol. Macromol. 2005, 36:116-119.
52. Souto E., Müller R.H. SLN and NLC for topical delivery of ketoconazole. J. Microencapsul. 2005, 22:501-510.
53. Souto E., Wissing S.A., Barbosa C.M., Müller R.H. Development of a controlled release formulation based on SLN and NLC for topical clotrimazole delivery. Int. J. Pharm. 2004, 278:71-77.
54. Souto E.B., Wissing S.A., Barbosa C.M., Muller R.H. Development of a controlled release formulation based on SLN and NLC for topical clotrimazole delivery. Int. J. Pharm. 2004, 278:71-77.
55. Stecova J., Mehnert W., Blaschke T., Kleuser B., Sivaramakrishnan R., Zouboulis C.C., Seltmann H., Korting H.C., Kramer K.D., Schafer-Korting M. Cyproterone acetate loading to lipid nanoparticles for topical acne treatment: particle characterisation and skin uptake. Pharm. Res. 2007, 24:991-1000.
56. Stecova J., Mehnert W., Blaschke T., Kleuser B., Sivaramakrishnan R., Zouboulis C.C., Seltmann H., Korting H.C., Kramer K.D., Schäfer-Korting M. Cyproterone acetate loading to lipid nanoparticles for topical acne treatment: particle characterisation and skin uptake. Pharm. Res. 2007, 24:991-1000.
57. Teeranachaideekul V. Nanostructured Lipid Carriers (NLC)-Stability Improvement and Release Modification of Ascorbyl Palmitate and Coenzyme Q10 2008, Mahidol University, Bankok.
58. Teeranachaideekul V., Boonme P., Souto E.B., Müller R.H., Junyaprasert V.B. Influence of oil content on physicochemical properties and skin distribution of Nile red-loaded NLC. J. Control. Rel. 2008, 128:134-141.
59. Teeranachaideekul V., Müller R.H., Junyaprasert V.B. Encapsulation of ascorbyl palmitate in nanostructured lipid carriers (NLC)-effects of formulation parameters on physicochemical stability. Int. J. Pharm. 2007, 340:198-206.
60. Teeranachaideekul V., Souto E.B., Junyaprasert V.B., Müller R.H. Cetyl palmitate-based NLC for topical delivery of Coenzyme Q(10)-development, physicochemical characterization and in vitro release studies. Eur. J. Pharm. Biopharm. 2007, 67:141-148.
61. Wissing S.A., Lippacher A., Müller R.H. Investigations on the occlusive properties of solid lipid nanoparticles (SLN). J. Cosmet. Sci. 2001, 52:313-324.
62. Wissing S.A., Müller R.H. A novel sunscreen system based on tocopherol acetate incorporated into solid lipid nanoparticles. Int. J. Cosmet. Sci. 2001, 23:233-243.
63. Wissing S.A., Müller R.H. The development of an improved carrier system for sunscreen formulations based on crystalline lipid nanoparticles. Int. J. Pharm. 2002, 242:373-375.
64. Wissing S.A., Müller R.H. Solid lipid nanoparticles as carrier for sunscreens: in vitro release and in vivo skin penetration. J. Control. Rel. 2002, 81:225-233.
65. Wissing S.A., Müller R.H. The influence of solid lipid nanoparticles on skin hydration and viscoelasticity-in vivo study. Eur. J. Pharm. Biopharm. 2003, 56:67-72.
66. Yaziksiz-Iscan Y., Wissing S.A., Müller R.H., Hekimoglu S. Different production methods for solid lipid nanoparticles (SLN) containing the insect repellent DEET. 4th World Meeting ADRITELF/APGI/APV, 2002.
67. Zhai H., Maibach H.I. Effects of skin occlusion on percutaneous absorption: an overview. Skin Pharmacol. Appl. Skin Physiol. 2001, 14:1-10.